Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1984 Jun;3(6):1383–1387. doi: 10.1002/j.1460-2075.1984.tb01981.x

The expression of cDNA clones of yeast M1 double-stranded RNA in yeast confers both killer and immunity phenotypes.

S Lolle, N Skipper, H Bussey, D Y Thomas
PMCID: PMC557527  PMID: 6086322

Abstract

Two cDNA clones of the segment of Saccharomyces cerevisiae M1 double-stranded RNA, which codes for the yeast killer toxin, have been expressed in yeast using the expression vector pYT760. Toxin expression and secretion depended upon the presence of a yeast promoter. Transformants not only contain an authentic preprotoxin precursor, as determined by precipitation of intracellular proteins with antitoxin antisera, but also display an immunity phenotype. The evidence is that the immunity protein is part of the preprotoxin and may act by masking toxin binding sites. Neither cDNA clone had a complete 5' terminus and the preprotoxin translational start was missing. The promoter and the initiator ATG were supplied by the expression vector. One clone with a full-length preprotoxin but altered N-terminal amino acids gave a normal glycosylated intracellular precursor. A clone with an N-terminal nine amino acid deletion gave a precursor which was not glycosylated but toxin was still secreted.

Full text

PDF
1383

Images in this article

1385Fig. 2.
on p.1385
1386Fig. 3.
on p.1386
1386Fig. 4.
on p.1386

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bostian K. A., Elliott Q., Bussey H., Burn V., Smith A., Tipper D. J. Sequence of the preprotoxin dsRNA gene of type I killer yeast: multiple processing events produce a two-component toxin. Cell. 1984 Mar;36(3):741–751. doi: 10.1016/0092-8674(84)90354-4. [DOI] [PubMed] [Google Scholar]
  2. Bostian K. A., Hopper J. E., Rogers D. T., Tipper D. J. Translational analysis of the killer-associated virus-like particle dsRNA genome of S. cerevisiae: M dsRNA encodes toxin. Cell. 1980 Feb;19(2):403–414. doi: 10.1016/0092-8674(80)90514-0. [DOI] [PubMed] [Google Scholar]
  3. Bostian K. A., Jayachandran S., Tipper D. J. A glycosylated protoxin in killer yeast: models for its structure and maturation. Cell. 1983 Jan;32(1):169–180. doi: 10.1016/0092-8674(83)90507-x. [DOI] [PubMed] [Google Scholar]
  4. Bussey H. Physiology of killer factor in yeast. Adv Microb Physiol. 1981;22:93–122. doi: 10.1016/s0065-2911(08)60326-4. [DOI] [PubMed] [Google Scholar]
  5. Bussey H., Sacks W., Galley D., Saville D. Yeast killer plasmid mutations affecting toxin secretion and activity and toxin immunity function. Mol Cell Biol. 1982 Apr;2(4):346–354. doi: 10.1128/mcb.2.4.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bussey H., Saville D., Greene D., Tipper D. J., Bostian K. A. Secretion of Saccharomyces cerevisiae killer toxin: processing of the glycosylated precursor. Mol Cell Biol. 1983 Aug;3(8):1362–1370. doi: 10.1128/mcb.3.8.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deng G., Wu R. Terminal transferase: use of the tailing of DNA and for in vitro mutagenesis. Methods Enzymol. 1983;100:96–116. doi: 10.1016/0076-6879(83)00047-6. [DOI] [PubMed] [Google Scholar]
  8. Gething M. J., Sambrook J. Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein. Nature. 1982 Dec 16;300(5893):598–603. doi: 10.1038/300598a0. [DOI] [PubMed] [Google Scholar]
  9. Hitzeman R. A., Hagie F. E., Levine H. L., Goeddel D. V., Ammerer G., Hall B. D. Expression of a human gene for interferon in yeast. Nature. 1981 Oct 29;293(5835):717–722. doi: 10.1038/293717a0. [DOI] [PubMed] [Google Scholar]
  10. Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983 Jan;153(1):163–168. doi: 10.1128/jb.153.1.163-168.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  12. Maxam A. M., Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499–560. doi: 10.1016/s0076-6879(80)65059-9. [DOI] [PubMed] [Google Scholar]
  13. Perlman D., Halvorson H. O., Cannon L. E. Presecretory and cytoplasmic invertase polypeptides encoded by distinct mRNAs derived from the same structural gene differ by a signal sequence. Proc Natl Acad Sci U S A. 1982 Feb;79(3):781–785. doi: 10.1073/pnas.79.3.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Racaniello V. R., Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 1981 Nov 20;214(4523):916–919. doi: 10.1126/science.6272391. [DOI] [PubMed] [Google Scholar]
  15. Skipper N., Thomas D. Y., Lau P. C. Cloning and sequencing of the preprotoxin-coding region of the yeast M1 double-stranded RNA. EMBO J. 1984 Jan;3(1):107–111. doi: 10.1002/j.1460-2075.1984.tb01769.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stepién P. P., Brousseau R., Wu R., Narang S., Thomas D. Y. Synthesis of a human insulin gene. VI. Expression of the synthetic proinsulin gene in yeast. Gene. 1983 Oct;24(2-3):289–297. doi: 10.1016/0378-1119(83)90089-6. [DOI] [PubMed] [Google Scholar]
  17. Taniguchi T., Palmieri M., Weissmann C. QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host. Nature. 1978 Jul 20;274(5668):223–228. doi: 10.1038/274223a0. [DOI] [PubMed] [Google Scholar]
  18. Thomas D. Y., Dubuc G., Narang S. Escherichia coli plasmid vectors containing synthetic translational initiation sequences and ribosome binding sites fused with the lacZ gene. Gene. 1982 Sep;19(2):211–219. doi: 10.1016/0378-1119(82)90008-7. [DOI] [PubMed] [Google Scholar]
  19. Wickner R. B. Genetic control of replication of the double-stranded RNA segments of the killer systems in Saccharomyces cerevisiae. Arch Biochem Biophys. 1983 Apr 1;222(1):1–11. doi: 10.1016/0003-9861(83)90496-4. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES